"John Nasseff Neuroscience Specialty Clinic is a comprehensive resource for patients with diverse neurological conditions."

During the past decade, John Nasseff Neuroscience Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Nasseff Neuroscience Institute" #1 collaborator was "Medelis Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "John Nasseff Neuroscience Institute" are "Glioblastoma Multiforme" (2 trials), "Glioblastoma" (1 trials), "Glioma" (1 trials), "Gliosarcoma" (1 trials) and "Malignant Brain Tumor" (1 trials). Many other conditions were trialed in "John Nasseff Neuroscience Institute" in a lesser frequency.

Most popular intervention types in "John Nasseff Neuroscience Institute" are "Drug" (2 trials), "Radiation" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Temozolomide" (2 trials), "Bevacizumab" (1 trials), "Enzastaurin Hydrochloride" (1 trials) and "ICT-107" (1 trials). Other intervention names were less common.

The vast majority of trials in "John Nasseff Neuroscience Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "John Nasseff Neuroscience Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in John Nasseff Neuroscience Institute, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in John Nasseff Neuroscience Institute, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".